PMC:7358770 / 14281-14450 JSONTXT

{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T33","span":{"begin":97,"end":104},"obj":"https://glytoucan.org/Structures/Glycans/G00021MO"},{"id":"T34","span":{"begin":97,"end":104},"obj":"https://glytoucan.org/Structures/Glycans/G54161DR"}],"text":"This study has implications for the rapid development of a first-line therapeutic by repurposing heparin and for next-generation, tailor-made, GAG-based antivirals [66]."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T165","span":{"begin":97,"end":104},"obj":"Body_part"},{"id":"T166","span":{"begin":143,"end":146},"obj":"Body_part"}],"attributes":[{"id":"A165","pred":"fma_id","subj":"T165","obj":"http://purl.org/sig/ont/fma/fma82839"},{"id":"A166","pred":"fma_id","subj":"T166","obj":"http://purl.org/sig/ont/fma/fma63011"}],"text":"This study has implications for the rapid development of a first-line therapeutic by repurposing heparin and for next-generation, tailor-made, GAG-based antivirals [66]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"469","span":{"begin":143,"end":146},"obj":"Chemical"}],"attributes":[{"id":"A469","pred":"tao:has_database_id","subj":"469","obj":"MESH:D006025"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"This study has implications for the rapid development of a first-line therapeutic by repurposing heparin and for next-generation, tailor-made, GAG-based antivirals [66]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T123","span":{"begin":11,"end":14},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T124","span":{"begin":57,"end":58},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"This study has implications for the rapid development of a first-line therapeutic by repurposing heparin and for next-generation, tailor-made, GAG-based antivirals [66]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T254","span":{"begin":97,"end":104},"obj":"Chemical"},{"id":"T255","span":{"begin":143,"end":146},"obj":"Chemical"},{"id":"T256","span":{"begin":153,"end":163},"obj":"Chemical"}],"attributes":[{"id":"A254","pred":"chebi_id","subj":"T254","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"},{"id":"A255","pred":"chebi_id","subj":"T255","obj":"http://purl.obolibrary.org/obo/CHEBI_143889"},{"id":"A256","pred":"chebi_id","subj":"T256","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"This study has implications for the rapid development of a first-line therapeutic by repurposing heparin and for next-generation, tailor-made, GAG-based antivirals [66]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T90","span":{"begin":0,"end":169},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This study has implications for the rapid development of a first-line therapeutic by repurposing heparin and for next-generation, tailor-made, GAG-based antivirals [66]."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T385","span":{"begin":97,"end":104},"obj":"CHEBI:24505;CHEBI:24505"},{"id":"T47355","span":{"begin":17,"end":27},"obj":"NCBITaxon:11886;UBERON:0001004"},{"id":"T87148","span":{"begin":28,"end":35},"obj":"NCBITaxon:10239"},{"id":"T13297","span":{"begin":45,"end":55},"obj":"NCBITaxon:11632"},{"id":"T46132","span":{"begin":57,"end":68},"obj":"NCBITaxon:11118"},{"id":"T69701","span":{"begin":70,"end":79},"obj":"NCBITaxon:7719"},{"id":"T9813","span":{"begin":80,"end":85},"obj":"NCBITaxon:10239"},{"id":"T5078","span":{"begin":145,"end":150},"obj":"UBERON:0000004"}],"text":"This study has implications for the rapid development of a first-line therapeutic by repurposing heparin and for next-generation, tailor-made, GAG-based antivirals [66]."}

{"project":"MyTest","denotations":[{"id":"469","span":{"begin":143,"end":146},"obj":"Chemical"}],"attributes":[{"id":"A469","pred":"tao:has_database_id","subj":"469","obj":"MESH:D006025"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"This study has implications for the rapid development of a first-line therapeutic by repurposing heparin and for next-generation, tailor-made, GAG-based antivirals [66]."}